20240917_INAF_Pengumuman RUPS_31726228_lamp2.pdf

                                ANNOUNCEMENT
                 EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS
                               PT INDOFARMA Tbk

Hereby the Board of Directors of PT Indofarma Tbk (“Company”) announce that the
Extraordinary General Meeting of Shareholders of Company (“EGMS”) will be held on
Thursday, October 24, 2024.

In accordance with Financial Services Authority Regulation Number 15/POJK.04/2020
concerning Plans and Implementation of General Meeting of Shareholders of Public
Companies     in    conjunction   with    Financial   Services   Authority    Regulation
Number 16/POJK.04/2020 concerning the Implementation of Electronic General Meeting
of Shareholders of Public Companies ("OJK Regulation”), the summons for the EGMS will be
made through the eASY.KSEI platform which can be accessed through
htpps://akses.ksei.co.id, the website of the e-GMS provider, the website
of the Indonesia Stock Exchange, and the website of the Company (www.indofarma.id) on
October 02, 2024.

Shareholders who are entitled to attend or be represented in the EGMS are Shareholders
whose names are registered in the Shareholders Register of the Company and/or owners
of the Company's share balances in the securities sub-account in the Collective Custody
of PT Kustodian Sentral Efek Indonesia (“KSEI”) at the close of stock trading on the Indonesia
Stock Exchange on October 01, 2024.

In accordance with OJK Regulation and Article 23 of the Company's Articles of Association,
1 (one) Shareholder or more representing 1/20 (one twentieth) or more of the total shares
issued by the Company with valid voting rights and Series A Shareholders Dwi Warna has
the right to propose the agenda of the EGMS which must be submitted in writing to the
Board of Directors of the Company no later than 7 (seven) days before the date of the
summons for the EGMS, September 25, 2024, accompanied by the reasons and materials
for the proposed EGMS agenda, and does not conflict with the statutory regulations.

                                Jakarta, September 17, 2024
                                     PT Indofarma Tbk
                                     Board of Directors